Literature DB >> 28936447

Lung cancer prognosis: can histological patterns and morphological features have a role in the management of lung cancer patients?

Silvia Rinaldi1, Rossana Berardi1.   

Abstract

Entities:  

Year:  2017        PMID： 28936447      PMCID： PMC5599273          DOI： 10.21037/atm.2017.05.18

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  15 in total

1.  Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.

Authors:  Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Journal:  Eur J Cancer       Date:  2010-01-04       Impact factor: 9.162

2.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  S Novello; F Barlesi; R Califano; T Cufer; S Ekman; M Giaj Levra; K Kerr; S Popat; M Reck; S Senan; G V Simo; J Vansteenkiste; S Peters
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

Review 4.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

5.  Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Authors:  Roy S Herbst; Paul Baas; Dong-Wan Kim; Enriqueta Felip; José L Pérez-Gracia; Ji-Youn Han; Julian Molina; Joo-Hang Kim; Catherine Dubos Arvis; Myung-Ju Ahn; Margarita Majem; Mary J Fidler; Gilberto de Castro; Marcelo Garrido; Gregory M Lubiniecki; Yue Shentu; Ellie Im; Marisa Dolled-Filhart; Edward B Garon
Journal:  Lancet       Date:  2015-12-19       Impact factor: 79.321

Review 6.  Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma.

Authors:  Alain C Borczuk
Journal:  Eur Respir Rev       Date:  2016-12

7.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

8.  Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.

Authors:  Jizhuang Luo; Qingyuan Huang; Rui Wang; Baohui Han; Jie Zhang; Heng Zhao; Wentao Fang; Qingquan Luo; Jun Yang; Yunhai Yang; Lei Zhu; Tianxiang Chen; Xinghua Cheng; Yiyang Wang; Jiajie Zheng; Han Wu; Weicong Xia; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-05       Impact factor: 4.553

9.  The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.

Authors:  Yang Zhang; Jing Li; Rui Wang; Yuan Li; Yunjian Pan; Deng Cai; Haichuan Hu; Hang Li; Ting Ye; Xiaoyang Luo; Yiliang Zhang; Bin Li; Lei Shen; Yihua Sun; Haiquan Chen
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

10.  Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.

Authors:  Rossana Berardi; Silvia Rinaldi; Matteo Santoni; Thomas Newsom-Davis; Michela Tiberi; Francesca Morgese; Miriam Caramanti; Agnese Savini; Consuelo Ferrini; Mariangela Torniai; Ilaria Fiordoliva; Marc Bower; Stefano Cascinu
Journal:  Oncotarget       Date:  2016-05-03
View more
  5 in total

1.  Prediction of Overall Survival of Patients with Completely Resected Non-Small Cell Lung Cancer: Analyses of Preoperative Spirometry, Preoperative Blood Tests, and Other Clinicopathological Data.

Authors:  Mengkun Shi; Cheng Zhan; Jialun Shi; Qun Wang
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

2.  The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.

Authors:  Peter Radeczky; Zsolt Megyesfalvi; Viktoria Laszlo; Janos Fillinger; Judit Moldvay; Erzsebet Raso; Erzsebet Schlegl; Tamas Barbai; Jozsef Timar; Ferenc Renyi-Vamos; Balazs Dome; Balazs Hegedus
Journal:  Transl Lung Cancer Res       Date:  2021-02

3.  Prognostic Value of Metabolic Tumor Parameters in Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan in Advanced Non-Small Cell Lung Cancer.

Authors:  Ayan Mallick; Jayanta Das; Manoj Kumar Shaw; Bivas Biswas; Soumendranath Ray
Journal:  Indian J Nucl Med       Date:  2021-06-21

4.  Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor.

Authors:  Peter Radeczky; Judit Moldvay; Janos Fillinger; Beata Szeitz; Bence Ferencz; Kristiina Boettiger; Melinda Rezeli; Krisztina Bogos; Ferenc Renyi-Vamos; Konrad Hoetzenecker; Balazs Hegedus; Zsolt Megyesfalvi; Balazs Dome
Journal:  Pathol Oncol Res       Date:  2021-09-23       Impact factor: 3.201

5.  Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma.

Authors:  Jun Chen; Chao Zhou; Ying Liu
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.